Ninth Annual Diabetes Conference: Providing Patient-Centered Diabetes Care March 16, 2013 Pre-test Question What is your professional designation? Number of Respondents 73 Pre-test Exit Test Post Test Question #1 A symptomatic patient with an A1C of 10.2% should consider an initial course of therapy with: Number of Respondents 75 71 25 Pre-test Exit Test Post Test Insulin Increase in learning from pre-test -6.00% 23.00% Question #2 Preserving β-cell function in T2DM is an important goal of therapy in type 2 diabetes: Number of Respondents 79 78 24 Pre-test Exit Test Post Test TRUE Increase in learning from pre-test -3.00% 1.00% Question #3 Which GLP-1 agonist causes the lowest incidence of nausea? Number of Respondents 72 78 25 Pre-test Exit Test Post Test Exenatide once weekly Increase in learning from pre-test 24.00% 3.00% Question #4 Which of the following combinations of anti-hyperglycemic agents is not recommended? Number of Respondents 67 22 25 Pre-test Exit Test Post Test Liraglutide + Sitagliptin Increase in learning from pre-test 20.00% 28.00% Question #5 By 10 years after clinical onset of Type 1 Diabetes, the pancreas is incapable of producing insulin. Number of Respondents 76 76 25 Pre-test Exit Test Post Test False Increase in learning from pre-test 45.00% 23.00% Correct answers in bold italics Ninth Annual Diabetes Conference: Providing Patient-Centered Diabetes Care March 16, 2013 Question #6 If Type 1 Diabetics have detectable beta cell mass then Incretin drug treatments may: Number of Respondents 68 75 25 Pre-test Exit Test Post Test All of the Above Increase in learning from pre-test 17.00% -6.00% Question #7 In the Diabetes Prevention Program (DPP) which lifestyle modifications were used to prevent or slow the progression to type 2 diabetes and are now the ADA recommended lifestyle changes? Number of Respondents 79 66 25 Pre-test Exit Test Post Test
Weight loss diet(low fat/low calorie) 200 minutes of
Weight loss diet (low carbohydrate/low calorie) 200 minutes
Weight loss diet (low fat/low calorie) 150 minutes of exercise per week
Weight loss diet (low carbohydrate/low calorie) 150 minutes
Increase in learning from pre-test 43.00% 16.00% Question #8 In patients at risk for diabetes, what % of body weight loss is recommended to help prevent diabetes? Number of Respondents 81 79 25 Pre-test Exit Test Post Test 5-10% weight loss Increase in learning from pre-test 21.00% -1.00% Question #9 Some conditions can result in falsely elevated A1c levels. Which of the following is not associated with elevated A1c values: Number of Respondents 69 70 25 Pre-test Exit Test Post Test Renal failure Increase in learning from pre-test 45.00% 26.00% Question #10 Which of the following are characteristics of successful PCMH programs: Number of Respondents 82 79 24 Pre-test Exit Test 4 All of the above Increase in learning from pre-test 6.00% 3.00% Overall Medians Median increase in learning from pre- to exit and post test Median number of respondents in pre-, exit and post tests Correct answers in bold italics Q12. What are you doing differently as a result of attending this activity?
I work primarily with type 1 pediatric patients. My practice has not changed
significantly, but I appreciate my increased knowledge.
Not alot since specifics not really covered as well as recent cd heard on diabetes
for test review puposes--am not using HGBA1C as diagnostic tool. THE ONETHINGS I AM STRESSING WITH EVERY glucose intolerant, diabetic or familyhistory patients is DAILY ACTIVITY and regular meal patterns each meal withprotein.
giving Metformin to pts with Metabolic Syndrome
Looking at the individual tailoring education working on team flow looking at
other reasons for elevated or lower A1C thinking in terms or prevention of type 1
Work in occ health. Pressing harder for employees with pre- diabetes to see
their personal doctors nd referring pre -diabetes employes to our in-housedietician. Have posters from conference vendors hung in my office
strong support of more of the team approach for pts
Recommending modifications of diabetic medication therapies
Using less SU, more DPP4 and GLP-1 meds, adding basal insulin sooner
Being more aggressive in treating diabetic patients.
Avoid the concomitant use of GLP-1 agonists and DPP4 inhibitors in therapy
Made some changes in order of meds used for Type 2 DM.
Being more aggressive with treatment of T2DM
I am trying to meet patients where they are on the continuum of change
checking annual vitamin B12 levels if on metformin
The focus group was a great additon and I enjoyed that as much as the
A polycystás petefészek szindróma – a metformin-dilemmaApolycystás ovarium szindróma (PCOS) Európában, így Magyarországon is a fogamzó-képes korú nôk mintegy 5–10%-át érinti, így a leggyakoribb nôi endokrin betegségnektekinthetô. Szimptomatológiája szerteágazó lehet, a tünetek rendszerbe foglalására akésôbbiekben természetesen kitérünk. Elsôdlegesen meddô